HCW Biologics’ HCW9218 study published in Journal of Virology
HCW Biologics says a new peer-reviewed study in the Journal of Virology reports promising results for drug candidate HCW9218 in a new indication for HIV treatment.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.